Colorectal cells grown into organoids, stem cell-derived human 'mini-organs' that are used to study human development and disease. NCI-funded researchers are working to advance our understanding of how to prevent, detect, and treat colorectal cancer CRC. They are also looking at what factors influence screening behaviors, how to address disparities, and the rising rates of CRC in younger people. This page highlights some of the latest research in colorectal cancer, including clinical advances that may soon translate into improved care, NCI-supported programs that are fueling progress, and research findings from recent studies.
Colorectal Cancer Research Results and Study Updates
Red meat intake, poor education linked to colorectal cancer | EurekAlert! Science News
Research is always going on in the area of colorectal cancer. Scientists are looking for causes and ways to prevent colorectal cancer, better ways to find it early when it's small and easier to treat , and ways to improve treatments. Here are some examples of current research. Treatment in a clinical trial is often the only way to get these treatments. Many studies are looking to identify the causes of colorectal cancer. The hope is that this might lead to new ways to help prevent it. For example, many studies have shown that aspirin and pain relievers like it might help lower the risk of colorectal cancer, but these drugs can have serious side effects.
Red meat intake, poor education linked to colorectal cancer
Cancer is the number two leading cause of death in the United States. The disease can strike almost any part of the body and is classified as an abnormal growth of cells. While it is true that 30 years ago a diagnosis of cancer was essentially a death sentence, modern science has advanced so rapidly that today, with screening and early detection, many forms of cancer are highly treatable and curable. Included among this list of highly curable cancers is colon cancer. Although the disease is deadly if not properly treated, many research papers from Paper Masters report that colon cancer, if caught in the earliest stages, has a 90 percent survival rate.
Combining text messaging with mailing people free at-home FIT kits helped increase screening for colorectal cancer among a predominantly Black population, a new study has found. Diagnoses of colorectal cancer continue to increase in younger adults. The Food and Drug Administration has approved encorafenib Braftovi in combination with cetuximab Erbitux to treat adults with metastatic colorectal cancer whose tumors have a specific mutation in the BRAF gene, called VE.